July 23-24, 2026 FDA meeting: The Pharmacy Compounding Advisory Committee will formally review BPC-157 (free base and acetate salt), KPV, TB-500, and MOTS-c at the FDA White Oak Campus
The peptide saga has been complicated, and categorizing these substances as "performance-enhancing drugs" is open to interpretation
Key Takeaways Angel Reyes & Associates was voted Best Personal Injury Lawyer and Best Accident Lawyer in Dallas-Fort Worth
Critical Requirements : Do NOT use if pregnant Do NOT use if planning pregnancy within 2 months Stop medication at least 2 months before planned pregnancy (allows medication to clear system) If pregnancy occurs while taking medication, stop immediately and contact healthcare provider Contraception During Treatment : Women of childbearing potential must use effective contraception Tirzepatide (Zepbound) may reduce oral contraceptive effectiveness
The responses to this question were almost identical to the previous question with the selected symptoms being vomiting (86%, n = 200), nausea (70%, n = 162), fullness (54%, n = 126), bloating (53%, n = 124), then upset stomach (46%, n = 108), lethargy (18%, n = 43), dizziness (14%, n = 32), other (9%, n = 20), loss of appetite (9%, n = 20), none (7%, n = 16), and headache (2%, n = 4) (Tables 6-8)
